Ehlers-Danlos syndrome type 3 clinical trials

The registry lists 28 studies for Ehlers-Danlos syndrome type 3 across 8 countries. 9 are recruiting or about to start. 22 of them are mainly about Ehlers-Danlos syndrome type 3 (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-22.

Get an email when these change. Save the Ehlers-Danlos syndrome type 3 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 13
Terminated: 4
Enrolling by invitation: 4
Recruiting: 3
Not yet recruiting: 2
Status unknown: 2

Phase

Phase 2: 2
Phase 1: 2

Where

United States: 11
France: 5
Canada: 4
Germany: 2
Sweden: 2
Poland: 1

Who runs them

University Health Network, Toronto (3) · Clarkson University (2) · Medical University of South Carolina (2) · Hospices Civils de Lyon (2) · Queen Mary University of London (1) · University Ghent (1) · Medical University of Warsaw (1) · University of Calgary (1)

What is being tested here

Drugs under test in Ehlers-Danlos syndrome type 3 studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	All
Glucose	1	1
Platelet rich plasma	1	1
Doxycycline	1	1
Oxytocin	0	1

Coming up

0phase 3 studies under way

4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Dec 2026STABLE Pilates for Hypermobility · Brigham and Women's Hospital
Dec 2026Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome · Medical College of Wisconsin
Feb 2027TMD-specific Physiotherapy in hEDS Patients Individuals With Hypermobile Ehlers-Danlos Syndrome · University Hospital Muenster
May 2027Hamstring Strengthening in Hypermobile Conditions · University of Calgary

Who these studies take

Of the 3 Ehlers-Danlos syndrome type 3 studies recruiting now, 1 (33%) set no upper age limit and 1 (33%) stop at 75 or younger. 1 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	1 (33%)	1 (33%)
18	3 (100%)	3 (100%)
30	2 (67%)	2 (67%)
40	2 (67%)	2 (67%)
50	2 (67%)	2 (67%)
65	2 (67%)	2 (67%)
75	2 (67%)	2 (67%)
85	1 (33%)	1 (33%)

Across all 28 studies, recruiting or not: 50% stop at 75 or younger and 43% at 65; 21% take children; 14% are for women only and 0% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 28 of 28. search them.